tirzepatide no longer shortage FDA confirms is still over, gives compounders a grace period ๐จ Alert: Tirzepatide No Longer
Description
Semaglutide and other GLP-1 receptor agonists are not recommended during pregnancy due to limited safety data in human pregnancies
The combination of GLP-1 and GIP agonists improves glycemic control and promotes weight loss
Provider-guided weight management with access to compounded medication options through telehealth.
#Wegovy, on the other hand, is what we reach for when obesity is the primary concern and diabetes is either not present or a secondary issue
